| Analyte |
Specimen |
Reference Range, Conventional Unit |
Conventional Unit |
Enter Quantity |
Conversion Factor (Multiply by) |
Reference Range, SI Unit |
Conversion Result |
SI Unit |
Convert |
Acetaminophen |
Serum, plasma |
10-30 |
g/mL |
|
6.614 |
66-200 |
|
mol/L |
|
Acetoacetate |
Serum, plasma |
<1 |
mg/dL |
|
97.95 |
<100 |
|
mol/L |
|
Acetone |
Serum, plasma |
<1.0 |
mg/dL |
|
0.172 |
<0.17 |
|
mmol/L |
|
Acid phosphatase |
Serum |
<5.5 |
U/L |
|
16.667 |
<90 |
|
nkat/L |
|
Activated partial thromboplastin time (APTT) |
Whole blood |
25-40 |
s |
|
1 |
25-40 |
|
s |
|
Adenosine deaminase |
Serum |
11.5-25.0 |
U/L |
|
16.667 |
190-420 |
|
nkat/L |
|
Adrenocorticotropic hormone (ACTH) |
Plasma |
<120 |
pg/mL |
|
0.22 |
<26 |
|
pmol/L |
|
Alanine |
Plasma |
1.87-5.89 |
mg/dL |
|
112.2 |
210-661 |
|
mol/L |
|
Alanine aminotransferase (ALT) |
Serum |
10-40 |
U/L |
|
0.0167 |
0.17-0.68 |
|
kat/L |
|
Albumin |
Serum |
3.5-5.0 |
g/dL |
|
10 |
35-50 |
|
g/L |
|
Alcohol dehydrogenase |
Serum |
<2.8 |
U/L |
|
16.667 |
<47 |
|
nkat/L |
|
Aldolase |
Serum |
1.0-7.5 |
U/L |
|
0.0167 |
0.02-0.13 |
|
kat/L |
|
Aldosterone |
Serum, plasma |
2-9 |
ng/dL |
|
27.74 |
55-250 |
|
pmol/L |
|
Alkaline phosphatase |
Serum |
30-120 |
U/L |
|
0.0167 |
0.5-2.0 |
|
kat/L |
|
Alprazolam |
Serum, plasma |
10-50 |
ng/mL |
|
3.24 |
32-162 |
|
nmol/L |
|
Amikacin |
Serum, plasma |
20-30 |
g/mL |
|
1.708 |
34-52 |
|
mol/L |
|
-Aminobutyric acid |
Plasma |
0.08-0.36 |
mg/dL |
|
96.97 |
8-35 |
|
mol/L |
|
-Aminolevulinic acid |
Serum |
15-23 |
g/dL |
|
0.0763 |
1.1-8.0 |
|
mol/L |
|
Amiodarone |
Serum, plasma |
0.5-2.5 |
g/mL |
|
1.55 |
0.8-3.9 |
|
mol/L |
|
Amitriptyline |
Plasma |
120-250 |
ng/mL |
|
3.605 |
433-903 |
|
nmol/L |
|
Ammonia (as nitrogen) |
Serum, plasma |
15-45 |
g/dL |
|
0.714 |
11-32 |
|
mol/L |
|
Amobarbital |
Serum |
1-5 |
g/mL |
|
4.42 |
4-22 |
|
mol/L |
|
Amphetamine |
Serum, plasma |
20-30 |
ng/mL |
|
7.4 |
148-222 |
|
nmol/L |
|
Amylase |
Serum |
27-131 |
U/L |
|
0.0167 |
0.46-2.23 |
|
kat/L |
|
Androstenedione |
Serum |
75-205 |
ng/dL |
|
0.0349 |
2.6-7.2 |
|
nmol/L |
|
Angiotensin I |
Plasma |
<25 |
pg/mL |
|
0.772 |
<15 |
|
pmol/L |
|
Angiotensin II |
Plasma |
10-60 |
pg/mL |
|
0.957 |
0.96-58 |
|
pmol/L |
|
Angiotensin-converting enzyme |
Serum |
<40 |
U/L |
|
16.667 |
<670 |
|
nkat/L |
|
Anion gap Na + (Cl - + HCO 3-) |
Serum, plasma |
8-16 |
mEq/L |
|
1 |
8-16 |
|
mmol/L |
|
Antidiuretic hormone (ADH) |
Plasma |
1-5 |
pg/mL |
|
0.923 |
0.9-4.6 |
|
pmol/L |
|
Antithrombin III |
Plasma |
21-30 |
mg/dL |
|
10 |
210-300 |
|
mg/L |
|
1-Antitrypsin |
Serum |
78-200 |
mg/dL |
|
0.184 |
14.5-36.5 |
|
mol/L |
|
Apolipoprotein A-I |
Serum |
80-151 |
mg/dL |
|
0.01 |
0.8-1.5 |
|
g/L |
|
Apolipoprotein B |
Serum, plasma |
50-123 |
mg/dL |
|
0.01 |
0.5-1.2 |
|
g/L |
|
Arginine |
Serum |
0.37-2.40 |
mg/dL |
|
57.05 |
21-138 |
|
mol/L |
|
Arsenic |
Whole blood |
<2-23 |
g/L |
|
0.0133 |
0.03-0.31 |
|
mol/L |
|
|
Asparagine |
Plasma |
0.40-0.91 |
mg/dL |
|
75.689 |
30-69 |
|
mol/L |
|
Aspartate aminotransferase (AST) |
Serum |
10-30 |
U/L |
|
0.0167 |
0.17-0.51 |
|
kat/L |
|
Aspartic acid |
Plasma |
<0.3 |
mg/dL |
|
75.13 |
<25 |
|
mol/L |
|
Atrial natriuretic hormone |
Plasma |
20-77 |
pg/mL |
|
0.325 |
6.5-2.5 |
|
pmol/L |
|
|
|
Base excess |
Whole blood |
2 to 3 |
mEg/L |
|
1 |
2 to 3 |
|
mmol/L |
|
Bicarbonate |
Serum |
21-28 |
mEq/L |
|
1 |
21-28 |
|
mmol/L |
|
Bile acids (total) |
Serum |
0.3-2.3 |
g/mL |
|
2.448 |
0.73-5.63 |
|
mol/L |
|
Bilirubin, total |
Serum |
0.3-1.2 |
mg/dL |
|
17.104 |
5.0-21.0 |
|
mol/L |
|
Bilirubin, direct (conjugated) |
Serum |
0.1-0.3 |
mg/dL |
|
17.104 |
1.7-5.1 |
|
mol/L |
|
Biotin |
Serum |
200-500 |
pg/mL |
|
0.00409 |
0.82-2.05 |
|
nmol/L |
|
Bismuth |
Whole blood |
1-12 |
g/L |
|
4.785 |
4.8-57.4 |
|
nmol/L |
|
Blood gases |
Carbon dioxide, Pco2 |
Arterial blood |
35-45 |
mm Hg |
|
0.133 |
4.7-5.9 |
|
kPa |
|
pH |
Arterial blood |
7.35-7.45 |
|
|
1 |
7.35-7.45 |
|
|
|
Oxygen, Po2 |
Arterial blood |
80-100 |
mm Hg |
|
0.133 |
11-13 |
|
kPa |
|
Brain-type natriuretic peptide (BNP) |
Plasma |
<167 |
pg/mL |
|
1 |
<167 |
|
ng/L |
|
Bromide (toxic) |
Serum |
>1250 |
g/mL |
|
0.0125 |
>15.6 |
|
mmol/L |
|
C1 esterase inhibitor |
Serum |
12-30 |
mg/dL |
|
10 |
120-300 |
|
mg/L |
|
C3 complement |
Serum |
1200-1500 |
g/mL |
|
0.001 |
1.2-1.5 |
|
g/L |
|
C4 complement |
Serum |
350-600 |
g/mL |
|
0.001 |
0.35-0.60 |
|
g/L |
|
Cadmium |
Whole blood |
0.3-1.2 |
g/L |
|
8.896 |
2.7-10.7 |
|
nmol/L |
|
Caffeine |
Serum, plasma |
3-15 |
g/L |
|
0.515 |
2.5-7.5 |
|
mol/L |
|
Calcitonin |
Plasma |
3-26 |
pg/mL |
|
0.292 |
0.8-7.6 |
|
pmol/L |
|
Calcium, ionized |
Serum |
4.60-5.08 |
mg/dL |
|
0.25 |
1.15-1.27 |
|
mmol/L |
|
Calcium, total |
Serum |
8.2-10.2 |
mg/dL |
|
0.25 |
2.05-2.55 |
|
mmol/L |
|
Cancer antigen (CA) 125 |
Serum |
<35 |
U/mL |
|
1 |
<35 |
|
kU/L |
|
Carbamazepine |
Serum, plasma |
8-12 |
g/mL |
|
4.233 |
34-51 |
|
mol/L |
|
Carbon dioxide (total) |
Serum, plasma |
22-28 |
mEq/L |
|
1 |
22-28 |
|
mmol/L |
|
Carboxyhemoglobin, toxic |
Whole blood |
>20 |
% |
|
0.01 |
>0.2 |
|
Proportion of 1.0 |
|
Carcinoembryonic antigen (CEA) |
Serum |
<3.0 |
ng/mL |
|
1 |
<3.0 |
|
g/L |
|
-Carotene |
Serum |
10-85 |
g/dL |
|
0.01863 |
0.2-1.6 |
|
mol/L |
|
Carotenoids |
Serum |
50-300 |
g/dL |
|
0.01863 |
0.9-5.6 |
|
mol/L |
|
Ceruloplasmin |
Serum |
20-40 |
mg/dL |
|
10 |
200-400 |
|
mg/L |
|
Chloramphenicol |
Serum |
10-25 |
g/mL |
|
3.095 |
31-77 |
|
mol/L |
|
Chlordiazepoxide |
Serum, plasma |
0.4-3.0 |
g/mL |
|
3.336 |
1.3-10.0 |
|
mol/L |
|
Chloride |
Serum, plasma |
96-106 |
mEq/L |
|
1 |
96-106 |
|
mmol/L |
|
Chlorpromazine |
Plasma |
50-300 |
ng/mL |
|
3.126 |
157-942 |
|
nmol/L |
|
Chlorpropamide |
Plasma |
75-250 |
mg/L |
|
3.61 |
270-900 |
|
mol/L |
|
|
|
|
|
|
|
|
|
|
|
Cholesterol (total) |
Desirable |
Serum, plasma |
<200 |
mg/dL |
|
0.0259 |
<5.18 |
|
mmol/L |
|
Borderline high |
Serum, plasma |
200-239 |
mg/dL |
|
0.0259 |
5.18-6.18 |
|
mmol/L |
|
High |
Serum, plasma |
240 |
mg/dL |
|
0.0259 |
 6.21 |
|
mmol/L |
|
Cholesterol, high-density (HDL) (low level) |
Serum, plasma |
<40 |
mg/dL |
|
0.0259 |
<1.03 |
|
mmol/L |
|
Cholesterol, low-density (LDL) (high level) |
Serum, plasma |
>160 |
mg/dL |
|
0.0259 |
4.144 |
|
mmol/L |
|
Cholinesterase |
Serum |
5-12 |
mg/L |
|
2.793 |
14-39 |
|
nmol/L |
|
Chorionic gonadotropin ( -hCG) (nonpregnant) |
Serum |
5 |
mIU/mL |
|
1 |
5 |
|
IU/L |
|
Chromium |
Whole blood |
0.7-28.0 |
g/L |
|
19.232 |
13.4-538.6 |
|
nmol/L |
|
Citrate |
Serum |
1.2-3.0 |
mg/dL |
|
52.05 |
60-160 |
|
mol/L |
|
Citrulline |
Plasma |
0.2-1.0 |
mg/dL |
|
57.081 |
12-55 |
|
mol/L |
|
Clonazepam |
Serum |
10-50 |
ng/mL |
|
0.317 |
0.4-15.8 |
|
nmol/L |
|
Clonidine |
Serum, plasma |
1.0-2.0 |
ng/mL |
|
4.35 |
4.4-8.7 |
|
nmol/L |
|
Clozapine |
Serum |
200-350 |
ng/mL |
|
0.003 |
0.6-1.0 |
|
mol/L |
|
Coagulation factor I |
Plasma |
0.15-0.35 |
g/dL |
|
29.41 |
4.4-10.3 |
|
mol/L |
|
(Fibrinogen) |
Plasma |
150-350 |
mg/dL |
|
0.01 |
1.5-3.5 |
|
g/L |
|
Coagulation factor II (prothrombin) |
Plasma |
70-130 |
% |
|
0.01 |
0.70-1.30 |
|
Proportion of 1.0 |
|
Coagulation factor V |
Plasma |
70-130 |
% |
|
0.01 |
0.70-1.30 |
|
Proportion of 1.0 |
|
Coagulation factor VII |
Plasma |
60-140 |
% |
|
0.01 |
0.60-1.40 |
|
Proportion of 1.0 |
|
Coagulation factor VIII |
Plasma |
50-200 |
% |
|
0.01 |
0.50-2.00 |
|
Proportion of 1.0 |
|
Coagulation factor IX |
Plasma |
70-130 |
% |
|
0.01 |
0.70-1.30 |
|
Proportion of 1.0 |
|
Coagulation factor X |
Plasma |
70-130 |
% |
|
0.01 |
0.70-1.30 |
|
Proportion of 1.0 |
|
Coagulation factor XI |
Plasma |
70-130 |
% |
|
0.01 |
0.70-1.30 |
|
Proportion of 1.0 |
|
Coagulation factor XII |
Plasma |
70-130 |
% |
|
0.01 |
0.70-1.30 |
|
Proportion of 1.0 |
|
Cobalt |
Serum |
4.0-10.0 |
g/L |
|
16.968 |
67.9-169.7 |
|
nmol/L |
|
Cocaine (toxic) |
Serum |
>1000 |
ng/mL |
|
3.297 |
>3300 |
|
nmol/L |
|
Codeine |
Serum |
10-100 |
ng/mL |
|
3.34 |
33-334 |
|
nmol/L |
|
Coenzyme Q10 (ubiquinone) |
Plasma |
0.5-1.5 |
g/mL |
|
1 |
0.5-1.5 |
|
mg/L |
|
Copper |
Serum |
70-140 |
g/dL |
|
0.157 |
44866 |
|
mol/L |
|
Coproporphyrin |
Urine |
<200 |
g/24 h |
|
1.527 |
<300 |
|
mol/d |
|
Corticotropin |
Plasma |
<120 |
pg/mL |
|
0.22 |
<26 |
|
pmol/L |
|
Cortisol |
Serum, plasma |
5-25 |
g/dL |
|
27.588 |
140-690 |
|
nmol/L |
|
Cotinine |
Plasma |
0-8 |
g/L |
|
5.675 |
0-45 |
|
nmol/L |
|
C-peptide |
Serum |
0.5-2.5 |
ng/mL |
|
0.331 |
0.17-0.83 |
|
nmol/L |
|
C-reactive protein |
Serum |
0.08-3.1 |
mg/L |
|
9.524 |
0.76-28.5 |
|
nmol/L |
|
Creatine |
Serum |
0.1-0.4 |
mg/dL |
|
76.25 |
8-31 |
|
mol/L |
|
Creatine kinase (CK) |
Serum |
40-150 |
U/L |
|
0.0167 |
0.67-2.5 |
|
kat/L |
|
Creatine kinase–MB fraction |
Serum |
0-7 |
ng/mL |
|
1 |
0-7 |
|
g/L |
|
Creatinine |
Serum, plasma |
0.6-1.2 |
mg/dL |
|
88.4 |
53-106 |
|
mol/L |
|
Creatinine clearance |
Serum, plasma |
75-125 |
mL/min/1.73m2 |
|
0.0167 |
1.24-2.08 |
|
mL/s/m2 |
|
Cyanide (toxic) |
Whole blood |
>1.0 |
g/mL |
|
23.24 |
>23 |
|
mol/L |
|
Cyclic adenosine monophosphate (cAMP) |
Plasma |
4.6-8.6 |
ng/mL |
|
3.04 |
14-26 |
|
mol/L |
|
Cyclosporine |
Serum |
100-400 |
ng/mL |
|
0.832 |
83-333 |
|
nmol/L |
|
Cystine |
Plasma |
0.40-1.40 |
mg/dL |
|
41.615 |
16-60 |
|
mol/L |
|
D-dimer |
Plasma |
<0.5 |
g/mL |
|
5.476 |
<3.0 |
|
nmol/L |
|
Dehydroepiandrosterone (DHEA) |
Serum |
1.8-12.5 |
ng/mL |
|
3.47 |
6.2-43.3 |
|
nmol/L |
|
Dehydroepiandrosterone sulfate (DHEA-S) |
Serum |
50-450 |
g/dL |
|
0.027 |
1.6-12.2 |
|
mol/L |
|
Deoxycorticosterone |
Serum |
2-19 |
ng/dL |
|
30.5 |
61-576 |
|
nmol/L |
|
Desipramine |
Serum, plasma |
50-200 |
ng/mL |
|
3.754 |
170-700 |
|
nmol/L |
|
Diazepam |
Serum, plasma |
100-1000 |
ng/mL |
|
0.0035 |
0.35-3.51 |
|
mol/L |
|
Digoxin |
Plasma |
0.5-2.0 |
ng/mL |
|
1.281 |
0.6-2.6 |
|
nmol/L |
|
Diltiazem |
Serum |
<200 |
mg/L |
|
2.412 |
<480 |
|
mol/L |
|
Disopyramide |
Serum, plasma |
2.8-7.0 |
g/mL |
|
2.946 |
8.3-22.0 |
|
mol/L |
|
Dopamine |
Plasma |
<87 |
pg/mL |
|
6.528 |
<475 |
|
pmol/L |
|
Doxepin |
Serum, plasma |
30-150 |
ng/mL |
|
3.579 |
108-538 |
|
nmol/L |
|
Electrophoresis (protein) |
Proportion of total protein |
Albumin |
Serum |
52-65 |
% |
|
0.01 |
0.52-0.65 |
|
Proportion of 1.0 |
|
1-Globulin |
Serum |
2.5-5.0 |
% |
|
0.01 |
0.025-0.05 |
|
Proportion of 1.0 |
|
2-Globulin |
Serum |
7.0-13.0 |
% |
|
0.01 |
0.07-0.13 |
|
Proportion of 1.0 |
|
-Globulin |
Serum |
8.0-14.0 |
% |
|
0.01 |
0.08-0.14 |
|
Proportion of 1.0 |
|
-Globulin |
Serum |
12.0-22.0 |
% |
|
0.01 |
0.12-0.22 |
|
Proportion of 1.0 |
|
Concentration |
Albumin |
Serum |
3.2-5.6 |
g/dL |
|
10 |
32-56 |
|
g/L |
|
1 -Globulin |
Serum |
0.1-0.4 |
g/dL |
|
10 |
1-10 |
|
g/L |
|
2 -Globulin |
Serum |
0.4-1.2 |
g/dL |
|
10 |
4-12 |
|
g/L |
|
-Globulin |
Serum |
0.5-1.1 |
g/dL |
|
10 |
5-11 |
|
g/L |
|
-Globulin |
Serum |
0.5-1.6 |
g/dL |
|
10 |
5-16 |
|
g/L |
|
|
Ephedrine (toxic) |
Serum |
>2 |
g/mL |
|
6.052 |
>12.1 |
|
mol/L |
|
Epinephrine |
Plasma |
<60 |
pg/mL |
|
5.459 |
<330 |
|
pmol/L |
|
|
Erythrocyte sedimentation rate |
Whole blood |
0-20 |
mm/h |
|
1 |
0-20 |
|
mm/h |
|
Erythropoietin |
Serum |
5-36 |
IU/L |
|
1 |
5-36 |
|
IU/L |
|
Estradiol (E 2 ) |
Serum |
30-400 |
pg/mL |
|
3.671 |
110-1470 |
|
pmol/L |
|
Estriol (E 3 ) |
Serum |
5-40 |
ng/mL |
|
3.467 |
17.4-138.8 |
|
nmol/L |
|
Estrogens (total) |
Serum |
60-400 |
pg/mL |
|
1 |
60-400 |
|
ng/L |
|
Estrone (E 1 ) |
Serum, plasma |
1.5-25.0 |
pg/mL |
|
3.698 |
5.5-92.5 |
|
pmol/L |
|
Ethanol (ethyl alcohol) |
Serum, whole blood |
<20 |
mg/dL |
|
0.2171 |
<4.3 |
|
mmol/L |
|
Ethchlorvynol (toxic) |
Serum, plasma |
>20 |
g/mL |
|
6.915 |
>138 |
|
mol/L |
|
Ethosuximide |
Serum |
40-100 |
mg/L |
|
7.084 |
280-700 |
|
mol/L |
|
Ethylene glycol (toxic) |
Serum, plasma |
>30 |
mg/dL |
|
0.1611 |
>5 |
|
mmol/L |
|
Fatty acids (nonesterified) |
Serum, plasma |
8-25 |
mg/dL |
|
0.0355 |
0.28-0.89 |
|
mmol/L |
|
Fecal fat (as stearic acid) |
Stool |
2.0-6.0 |
g/d |
|
1 |
2-6 |
|
g/24 h |
|
Fenfluramine |
Serum |
0.04-0.30 |
g/mL |
|
4.324 |
0.18-1.30 |
|
mol/L |
|
Fentanyl |
Serum |
0.01-0.10 |
g/mL |
|
2.972 |
0.02-0.30 |
|
mol/L |
|
Ferritin |
Serum |
15-200 |
ng/mL |
|
2.247 |
33-450 |
|
pmol/Lng/mL |
|
1 -Fetoprotein |
Serum |
<10 |
ng/mL |
|
1 |
<10 |
|
g/L |
|
Fibrin degradation products |
Plasma |
<10 |
g/mL |
|
1 |
<10 |
|
mg/L |
|
Fibrinogen |
Plasma |
200-400 |
mg/dL |
|
0.0294 |
5.8-11.8 |
|
mol/L |
|
Flecanide |
Serum, plasma |
0.2-1.0 |
g/mL |
|
2.413 |
0.5-2.4 |
|
mol/L |
|
Fluoride |
Whole blood |
<0.05 |
mg/dL |
|
0.5263 |
<0.027 |
|
mmol/L |
|
Fluoxetine |
Serum |
200-1100 |
ng/mL |
|
0.00323 |
0.65-3.56 |
|
mol/L |
|
Flurazepam (toxic) |
Serum, plasma |
>0.2 |
g/mL |
|
2.5 |
>0.5 |
|
mol/L |
|
Folate (folic acid) |
Serum |
3-16 |
ng/mL |
|
2.266 |
7-36 |
|
nmol/L |
|
Follicle-stimulating hormone (FSH) |
Serum, plasma |
1-100 |
mIU/mL |
|
1 |
1-100 |
|
IU/L |
|
Fructosamine |
Serum |
36-50 |
mg/L |
|
5.581 |
200-280 |
|
mmol/L |
|
Fructose |
Serum |
1-6 |
mg/dL |
|
55.506 |
55-335 |
|
mol/L |
|
Galactose |
Serum, plasma |
<20 |
mg/dL |
|
0.0555 |
<1.10 |
|
mmol/L |
|
Gastrin |
Serum |
25-90 |
pg/mL |
|
0.481 |
12-45 |
|
pmol/L |
|
Gentamicin |
Serum |
6-10 |
g/mL |
|
2.09 |
12-21 |
|
mol/L |
|
Glucagon |
Plasma |
20-100 |
pg/mL |
|
1 |
20-100 |
|
ng/L |
|
Glucose |
Serum |
70-110 |
mg/dL |
|
0.0555 |
3.9-6.1 |
|
mmol/L |
|
Glucose-6-phosphate dehydrogenase |
Whole blood |
10-14 |
U/g hemoglobin |
|
0.0167 |
0.17-0.24 |
|
nkat/g hemoglobin |
|
Glutamic acid |
Plasma |
0.2-2.8 |
mg/dL |
|
67.967 |
15-190 |
|
mol/L |
|
Glutamine |
Plasma |
6.1-10.2 |
mg/dL |
|
68.423 |
420-700 |
|
mol/L |
|
-Glutamyltransferase (GGT) |
Serum |
2-30 |
U/L |
|
0.0167 |
0.03-0.51 |
|
kat/L |
|
Glutethimide |
Serum |
2-6 |
g/mL |
|
4.603 |
9-28 |
|
mol/L |
|
Glycerol (free) |
Serum |
0.3-1.72 |
mg/dL |
|
0.1086 |
0.32-0.187 |
|
mmol/L |
|
Glycine |
Plasma |
0.9-4.2 |
mg/dL |
|
133.2 |
120-560 |
|
mol/L |
|
Gold |
Serum |
<10 |
g/dL |
|
50.77 |
<500 |
|
nmol/L |
|
Growth hormone (GH) |
Serum |
0-18 |
ng/mL |
|
1 |
0-18 |
|
g/L |
|
Haloperidol |
Serum, Plasma |
6-24 |
ng/mL |
|
2.66 |
16-65 |
|
nmol/L |
|
Haptoglobin |
Serum |
26-185 |
mg/dL |
|
10 |
260-1850 |
|
mg/L |
|
Hematocrit |
Whole blood |
41-50 |
% |
|
0.01 |
0.41-0.50 |
|
Proportion of 1.0 |
|
Hemoglobin |
Whole blood |
14.0-17.5 |
g/dL |
|
10 |
140-175 |
|
g/L |
|
Mean corpuscular hemoglobin (MCH) |
Whole blood |
26-34 |
pg/cell |
|
1 |
26-34 |
|
pg/cell |
|
Mean corpuscular hemoglobin concentration (MCHC) |
Whole blood |
33-37 |
g/dL |
|
10 |
330-370 |
|
g/L |
|
Mean corpuscular volume (MCV) |
Whole blood |
80-100 |
m3 |
|
1 |
80-100 |
|
fL |
|
Hemoglobin A 1c (glycated hemoglobin) |
Whole blood |
4-7 |
% of total hemoglobin |
|
0.01 |
0.04-0.07 |
|
Proportion of total hemoglobin |
|
Hemoglobin A 2 |
Whole blood |
2.0-3.0 |
% |
|
0.01 |
0.02-0.03 |
|
Proportion of 1.0 |
|
Histamine |
Plasma |
0.5-1.0 |
g/L |
|
8.997 |
4.5-9.0 |
|
nmol/L |
|
Histidine |
Plasma |
0.5-1.7 |
mg/dL |
|
64.45 |
32-110 |
|
mol/L |
|
Homocysteine |
Plasma |
0.68-2.02 |
mg/L |
|
7.397 |
5-15 |
|
mol/L |
|
Homovanillic acid |
Urine |
1.4-8.8 |
mg/24 h |
|
5.489 |
8-48 |
|
mol/d |
|
Hydrocodone |
Serum |
<0.02 |
g/mL |
|
3.34 |
<0.06 |
|
mol/L |
|
Hydromorphone |
Serum |
0.008-0.032 |
g/mL |
|
3504 |
28-112 |
|
nmol/L |
|
-Hydroxybutyric acid |
Plasma |
<3.0 |
mg/dL |
|
96.06 |
<300 |
|
mol/L |
|
5-Hydroxyindoleacetic acid (5-HIAA) |
Urine |
2-6 |
mg/24 h |
|
5.23 |
10.4-31.2 |
|
mol/d |
|
Hydroxyproline |
Plasma |
<0.55 |
mg/dL |
|
76.266 |
<42 |
|
mol/L |
|
Ibuprofen |
Serum |
10-50 |
g/mL |
|
4.848 |
50-243 |
|
mol/L |
|
Imipramine |
Plasma |
150-250 |
ng/mL |
|
3.566 |
536-893 |
|
nmol/L |
|
Immunoglobulin A (IgA) |
Serum |
40-350 |
mg/dL |
|
10 |
400-3500 |
|
mg/L |
|
Immunoglobulin D (IgD) |
Serum |
0-8 |
mg/dL |
|
10 |
0-80 |
|
mg/L |
|
Immunoglobulin E (IgE) |
Serum |
0-1500 |
g/L |
|
0.001 |
0-1.5 |
|
mg/L |
|
Immunoglobulin G (IgG) |
Serum |
650-1600 |
mg/dL |
|
0.01 |
6.5-16.0 |
|
g/L |
|
Immunoglobulin M (IgM) |
Serum |
54-300 |
mg/dL |
|
10 |
550-3000 |
|
mg/L |
|
Insulin |
Serum |
2.0-20 |
IU/mL |
|
6.945 |
14-140 |
|
pmol/L |
|
Insulinlike growth factor |
Serum |
130-450 |
ng/mL |
|
0.131 |
18-60 |
|
nmol/L |
|
Iodine |
Serum |
58-77 |
g/L |
|
7.88 |
450-580 |
|
nmol/L |
|
Iron |
Serum |
60-150 |
g/dL |
|
0.179 |
10.7-26.9 |
|
mol/L |
|
Iron-binding capacity |
Serum |
250-450 |
g/dL |
|
0.179 |
44.8-80.6 |
|
mol/L |
|
Isoleucine |
Plasma |
0.5-1.3 |
mg/dL |
|
76.236 |
40-100 |
|
mol/L |
|
Isoniazid |
Plasma |
1-7 |
g/mL |
|
7.291 |
7-51 |
|
mol/L |
|
Isopropanol (toxic) |
Serum, plasma |
>400 |
mg/L |
|
0.0166 |
>6.64 |
|
mmol/L |
|
Kanamycin |
Serum, plasma |
25-35 |
g/mL |
|
2.08 |
52-72 |
|
mol/L |
|
Ketamine |
Serum |
0.2-6.3 |
g/mL |
|
4.206 |
0.8-26 |
|
mol/L |
|
17-Ketosteroids |
Urine |
3-12 |
mg/24 h |
|
3.33 |
10-42 |
|
mol/d |
|
Lactate |
Plasma |
5.0-15 |
mg/dL |
|
0.111 |
0.6-1.7 |
|
mmol/L |
|
Lactate dehydrogenase (LDH) |
Serum |
100-200 |
U/L |
|
0.0167 |
1.7-3.4 |
|
kat/L |
|
LDH isoenzymes |
LD1 |
Serum |
17-27 |
% |
|
0.01 |
0.17-0.27 |
|
Proportion of 1.0 |
|
LD2 |
Serum |
27-37 |
% |
|
0.01 |
0.27-0.37 |
|
Proportion of 1.0 |
|
LD3 |
Serum |
18-25 |
% |
|
0.01 |
0.18-0.25 |
|
Proportion of 1.0 |
|
LD4 |
Serum |
3-8 |
% |
|
0.01 |
0.03-0.08 |
|
Proportion of 1.0 |
|
LD5 |
Serum |
0-5 |
% |
|
0.01 |
0-0.05 |
|
Proportion of 1.0 |
|
Lead |
Serum |
<10-20 |
g/dL |
|
0.0483 |
<0.5-1.0 |
|
mol/L |
|
Leucine |
Plasma |
1.0-2.3 |
mg/dL |
|
76.237 |
75-175 |
|
mol/L |
|
|
Lidocaine |
Serum, plasma |
1.5-6.0 |
g/mL |
|
4.267 |
6.4-25.6 |
|
mol/L |
|
Lipase |
Serum |
31-186 |
U/L |
|
0.0167 |
0.5-3.2 |
|
kat/L |
|
Lipoprotein(a) [Lp(a)] |
Serum |
10-30 |
mg/dL |
|
0.0357 |
0.35-1.0 |
|
mol/L |
|
Lithium |
Serum |
0.6-1.2 |
mEq/L |
|
1 |
0.6-1.2 |
|
mmol/L |
|
Lorazepam |
Serum |
50-240 |
ng/mL |
|
3.114 |
156-746 |
|
nmol/L |
|
Luteinizing hormone (LH) |
Serum, plasma |
1-104 |
mIU/mL |
|
1 |
1-104 |
|
IU/L |
|
Lycopene |
Serum |
0.15-0.25 |
mg/L |
|
1.863 |
0.28-0.46 |
|
mol/L |
|
|
Lysergic acid diethylamide |
Serum |
<0.004 |
g/mL |
|
3726 |
<15 |
|
nmol/L |
|
Lysine |
Plasma |
1.2-3.5 |
mg/dL |
|
68.404 |
80-240 |
|
mol/L |
|
Lysozyme |
Serum, plasma |
0.4-1.3 |
mg/dL |
|
10 |
4-13 |
|
mg/L |
|
Magnesium |
Serum |
1.3-2.1 |
mEq/L |
|
0.5 |
0.65-1.05 |
|
mmol/L |
|
Manganese |
Whole blood |
10-12 |
g/L |
|
18.202 |
182-218 |
|
nmol/L |
|
Maprotiline |
Plasma |
200-600 |
ng/mL |
|
1 |
200-600 |
|
g/L |
|
Melatonin |
Serum |
10-15 |
ng/L |
|
4.305 |
45-66 |
|
pmol/L |
|
Meperidine |
Serum, plasma |
400-700 |
ng/mL |
|
4.043 |
1620-2830 |
|
nmol/L |
|
Mercury |
Serum |
<5 |
g/L |
|
4.985 |
<25 |
|
nmol/L |
|
Metanephrine (total) |
Urine |
<1.0 |
mg/24 h |
|
5.07 |
<5 |
|
mol/d |
|
Metformin |
Serum |
1-4 |
g/mL |
|
7.742 |
8-30 |
|
mol/L |
|
Methadone |
Serum, plasma |
100-400 |
ng/mL |
|
0.00323 |
0.32-1.29 |
|
mol/L |
|
Methamphetamine |
Serum |
0.01-0.05 |
g/mL |
|
6.7 |
0.07-0.34 |
|
mol/L |
|
Methanol |
Plasma |
<200 |
g/mL |
|
0.0312 |
<6.2 |
|
mmol/L |
|
Methaqualone |
Serum, plasma |
2-3 |
g/mL |
|
4 |
8-12 |
|
mol/L |
|
Methemoglobin |
Whole blood |
<0.24 |
g/dL |
|
155 |
<37.2 |
|
mol/L |
|
Methemoglobin |
Whole blood |
<1.0 |
% of total hemoglobin |
|
0.01 |
<0.01 |
|
Proportion of total hemoglobin |
|
Methicillin |
Serum |
8-25 |
mg/L |
|
2.636 |
22-66 |
|
mol/L |
|
Methionine |
Plasma |
0.1-0.6 |
mg/dL |
|
67.02 |
6-40 |
|
mol/L |
|
Methotrexate |
Serum, plasma |
0.04-0.36 |
mg/L |
|
2200 |
90-790 |
|
nmol/L |
|
Methyldopa |
Plasma |
1-5 |
g/mL |
|
4.735 |
5.0-25 |
|
mol/L |
|
Metoprolol |
Serum, plasma |
75-200 |
ng/mL |
|
3.74 |
281-748 |
|
nmol/L |
|
2 -Microglobulin |
Serum |
1.2-2.8 |
mg/L |
|
1 |
1.2-2.8 |
|
mg/L |
|
Morphine |
Serum, plasma |
10-80 |
ng/mL |
|
3.504 |
35-280 |
|
nmol/L |
|
Myoglobin |
Serum |
19-92 |
g/L |
|
0.0571 |
1.0-5.3 |
|
nmol/L |
|
Naproxen |
Serum |
26-70 |
g/mL |
|
4.343 |
115-300 |
|
mol/L |
|
Niacin (nicotinic acid) |
Urine |
2.4-6.4 |
mg/24 h |
|
7.3 |
17.5-46.7 |
|
mol/d |
|
Nickel |
Whole blood |
1.0-28.0 |
g/L |
|
17.033 |
17-476 |
|
nmol/L |
|
Nicotine |
Plasma |
0.01-0.05 |
mg/L |
|
6.164 |
0.062-0.308 |
|
mol/L |
|
Nitrogen (nonprotein) |
Serum |
20-35 |
mg/dL |
|
0.714 |
14.3-25.0 |
|
mmol/L |
|
Nitroprusside (as thiocyanate) |
|
6-29 |
g/mL |
|
17.2 |
103-500 |
|
mol/L |
|
Norepinephrine |
Plasma |
110-410 |
pg/mL |
|
5.911 |
650-2423 |
|
pmol/L |
|
Nortriptyline |
Serum, plasma |
50-150 |
ng/mL |
|
3.797 |
190-570 |
|
nmol/L |
|
Ornithine |
Plasma |
0.4-1.4 |
mg/dL |
|
75.666 |
30-106 |
|
mol/L |
|
Osmolality |
Serum |
275-295 |
mOsm/kg |
|
1 |
275-295 |
|
mmol/kg |
|
Osteocalcin |
Serum |
3.0-13.0 |
ng/mL |
|
1 |
3.0-13.0 |
|
g/L |
|
Oxalate |
Serum |
1.0-2.4 |
mg/mL |
|
11.107 |
11-27 |
|
mol/L |
|
Oxazepam |
Serum, plasma |
0.2-1.4 |
g/mL |
|
3.487 |
0.7-4.9 |
|
mol/L |
|
Oxycodone |
Serum |
10-100 |
ng/mL |
|
3.171 |
32-317 |
|
nmol/L |
|
Oxygen, partial pressure (Po 2 ) |
Arterial blood |
80-100 |
mm Hg |
|
0.133 |
11-13 |
|
kPa |
|
Paraquat |
Whole blood |
0.1-1.6 |
g/mL |
|
5.369 |
0.5-8.5 |
|
mol/L |
|
Parathyroid hormone |
Serum |
10-65 |
pg/mL |
|
1 |
10-65 |
|
ng/L |
|
Pentobarbital |
Serum, plasma |
1-5 |
g/mL |
|
4.439 |
4.0-22 |
|
mol/L |
|
Pepsinogen |
Serum |
28-100 |
ng/mL |
|
1 |
28-100 |
|
g/L |
|
|
Phencyclidine (toxic) |
Serum, plasma |
90-800 |
ng/mL |
|
4.109 |
370-3288 |
|
nmol/L |
|
Phenobarbital |
Serum, plasma |
15-40 |
g/mL |
|
4.31 |
65-172 |
|
mol/L |
|
Phenylalanine |
Plasma |
0.6-1.5 |
mg/dL |
|
60.544 |
35-90 |
|
mol/L |
|
Phenylpropanolamine |
Serum |
0.05-0.10 |
g/mL |
|
6613 |
330-660 |
|
nmol/L |
|
Phenytoin |
Serum, plasma |
10-20 |
mg/L |
|
3.968 |
40-79 |
|
mol/L |
|
Phosphorus (inorganic) |
Serum |
2.3-4.7 |
mg/dL |
|
0.323 |
0.74-1.52 |
|
mmol/L |
|
Placental lactogen |
Serum |
0.5-1.1 |
g/mL |
|
46.296 |
23-509 |
|
nmol/L |
|
Plasminogen (antigenic) |
Plasma |
10-20 |
mg/dL |
|
0.113 |
1.1-2.2 |
|
mol/L |
|
Plasminogen activator inhibitor |
Plasma |
4-40 |
ng/mL |
|
19.231 |
75-750 |
|
pmol/L |
|
Platelet count (thrombocytes) |
Whole blood |
150-350 |
×10 3/ L |
|
1 |
150-350 |
|
×109/L |
|
Porphyrins (total) |
Urine |
20-120 |
g/L |
|
1.203 |
25-144 |
|
nmol/L |
|
Potassium |
Serum |
3.5-5.0 |
mEq/L |
|
1 |
3.5-5.0 |
|
mmol/L |
|
Prealbumin |
Serum |
19.5-35.8 |
mg/dL |
|
10 |
195-358 |
|
mg/L |
|
Pregnanediol |
Urine |
<2.6 |
mg/24 h |
|
3.12 |
<8 |
|
mol/d |
|
Pregnanetriol |
Urine |
<2.5 |
mg/24 h |
|
2.972 |
<7.5 |
|
mol/d |
|
Primidone |
Serum, plasma |
5-12 |
g/mL |
|
4.582 |
23-55 |
|
mol/L |
|
Procainamide |
Serum, plasma |
4-10 |
g/mL |
|
4.25 |
17-42 |
|
mol/L |
|
Progesterone |
Serum |
0.15-25 |
ng/mL |
|
3.18 |
0.5-79.5 |
|
nmol/L |
|
Prolactin |
Serum |
3.8-23.2 |
g/L |
|
43.478 |
90-140 |
|
pmol/L |
|
Proline |
Plasma |
1.2-3.9 |
mg/dL |
|
86.858 |
104-340 |
|
mol/L |
|
Propoxyphene |
Plasma |
0.1-0.4 |
g/mL |
|
2.946 |
0.3-1.2 |
|
mol/L |
|
Propranolol |
Serum |
50-100 |
ng/mL |
|
3.856 |
193-386 |
|
nmol/L |
|
Prostate-specific antigen |
Serum |
<4.0 |
ng/mL |
|
1 |
<4.0 |
|
g/L |
|
Protein (total) |
Serum |
6.0-8.0 |
g/dL |
|
10 |
60-80 |
|
g/L |
|
Prothrombin time (PT) |
Plasma |
10-13 |
s |
|
1 |
10-13 |
|
s |
|
Protoporphyrin |
Red blood cells |
15-50 |
g/dL |
|
0.0178 |
0.27-0.89 |
|
mol/L |
|
Protriptyline |
Serum, plasma |
70-250 |
g/dL |
|
3.787 |
266-950 |
|
nmol/L |
|
|
Pyruvate |
Plasma |
0.5-1.5 |
mg/dL |
|
113.56 |
60-170 |
|
mol/L |
|
Quinidine |
Serum |
2.0-5.0 |
g/mL |
|
3.082 |
6.2-15.4 |
|
mol/L |
|
Red blood cell count |
Whole blood |
3.9-5.5 |
×10 6/ L |
|
1 |
3.9-5.5 |
|
×1012/L |
|
Renin |
Plasma |
30-40 |
pg/mL |
|
0.0237 |
0.7-1.0 |
|
pmol/L |
|
Reticulocyte count |
Whole blood |
25-75 |
×10 3/ L |
|
1 |
25-75 |
|
×109/L |
|
Reticulocyte count |
Whole blood |
0.5-1.5 |
% of red blood cells |
|
0.01 |
0.005-0.015 |
|
Proportion of red blood cells |
|
|
|
Rifampin |
Serum |
4-40 |
mg/L |
|
1.215 |
5-49 |
|
mol/L |
|
Salicylates |
Serum, plasma |
150-300 |
g/mL |
|
0.0724 |
1086-2172 |
|
mol/L |
|
Selenium |
Serum, plasma |
58-234 |
g/L |
|
0.0127 |
0.74-2.97 |
|
mol/L |
|
Serine |
Plasma |
0.7-2.0 |
mg/dL |
|
95.156 |
65-193 |
|
mol/L |
|
Serotonin (5-hydroxytryptamine) |
Whole blood |
50-200 |
ng/mL |
|
0.00568 |
0.28-1.14 |
|
mol/L |
|
Sex hormone-binding globulin |
Serum |
1.5-2.0 |
g/mL |
|
8.896 |
13-17 |
|
nmol/L |
|
Sodium |
Serum |
136-142 |
mEq/L |
|
1 |
136-142 |
|
mmol/L |
|
Somatomedin C (Insulinlike growth factor) |
Serum |
130-450 |
ng/mL |
|
0.131 |
18-60 |
|
nmol/L |
|
Somatostatin |
Plasma |
<25 |
pg/mL |
|
0.611 |
<15 |
|
pmol/L |
|
Streptomycin |
Serum |
7-50 |
mg/L |
|
1.719 |
12-86 |
|
mol/L |
|
Strychnine |
Whole blood |
<0.5 |
mg/L |
|
2.99 |
<1.5 |
|
mol/L |
|
Substance P |
Plasma |
<240 |
pg/mL |
|
0.742 |
<180 |
|
pmol/L |
|
Sulfate |
Serum |
10-32 |
mg/L |
|
31.188 |
310-990 |
|
mol/L |
|
Sulfmethemoglobin |
Whole blood |
<1.0 |
% of total hemoglobin |
|
0.01 |
<0.010 |
|
Proportion of total hemoglobin |
|
Taurine |
Plasma |
0.3-2.1 |
mg/dL |
|
79.91 |
24-168 |
|
mol/L |
|
Testosterone |
Serum |
300-1200 |
ng/dL |
|
0.0347 |
10.4-41.6 |
|
nmol/L |
|
Tetrahydrocannabinol |
Serum |
<0.20 |
g/mL |
|
3.18 |
<0.60 |
|
mol/L |
|
Theophylline |
Serum, plasma |
10-20 |
g/mL |
|
5.55 |
56-111 |
|
mol/L |
|
|
Thiopental |
Serum, plasma |
1-5 |
g/mL |
|
4.144 |
4.1-20.7 |
|
mol/L |
|
Thioridazine |
Serum, plasma |
1.0-1.5 |
g/mL |
|
2.699 |
2.7-4.1 |
|
mol/L |
|
Threonine |
Plasma |
0.9-2.5 |
mg/dL |
|
84 |
75-210 |
|
mol/L |
|
Thrombin time |
Plasma |
16-24 |
s |
|
1 |
16.24 |
|
s |
|
|
Thyroglobulin |
Serum |
3-42 |
ng/mL |
|
1 |
3-42 |
|
g/L |
|
Thyroid-stimulating hormone (TSH) |
Serum |
0.4-4.2 |
mIU/L |
|
1 |
0.4-4.2 |
|
mIU/L |
|
Thyroxine, free (FT 4 ) |
Serum |
0.9-2.3 |
ng/dL |
|
12.871 |
12-30 |
|
pmol/L |
|
Thyroxine, total (T 4 ) |
Serum |
5.5-12.5 |
g/mL |
|
17.094 |
206-309 |
|
nmol/L |
|
Thyroxine-binding globulin |
Serum |
16.0-24.0 |
g/mL |
|
17.094 |
206-309 |
|
nmol/L |
|
Tissue plasminogen activator |
Plasma |
<0.04 |
IU/mL |
|
1000 |
<40 |
|
IU/L |
|
Tobramycin |
Serum, plasma |
5-10 |
g/mL |
|
2.139 |
10-21 |
|
mol/L |
|
Tocainide |
Serum |
4-10 |
g/mL |
|
5.201 |
21-52 |
|
mol/L |
|
|
Tolbutamide |
Serum |
80-240 |
g/mL |
|
3.7 |
296-888 |
|
mol/L |
|
Transferrin |
Serum |
200-400 |
mg/dL |
|
0.0123 |
2.5-5.0 |
|
mol/L |
|
Triglycerides |
Serum |
<160 |
mg/dL |
|
0.0113 |
1.8 |
|
mmol/L |
|
Triiodothyronine, free (FT3) |
Serum |
130-450 |
pg/dL |
|
0.0154 |
2.0-7.0 |
|
pmol/L |
|
Triiodothyronine, total (T3) |
Serum |
60-180 |
ng/dL |
|
0.0154 |
0.92-2.76 |
|
nmol/L |
|
Troponin I |
Serum |
0-0.4 |
ng/mL |
|
1 |
0-0.4 |
|
g/L |
|
Troponin T |
Serum |
0-0.1 |
ng/mL |
|
1 |
0-0.1 |
|
g/L |
|
Tryptophan |
Plasma |
0.5-1.5 |
mg/dL |
|
48.967 |
25-73 |
|
mol/L |
|
Tyrosine |
Plasma |
0.4-1.6 |
mg/dL |
|
55.19 |
20-90 |
|
mol/L |
|
Urea nitrogen |
Serum |
8-23 |
mg/dL |
|
0.357 |
2.9-8.2 |
|
mmol/L |
|
Uric acid |
Serum |
4.0-8.0 |
mg/dL |
|
59.485 |
240-480 |
|
mol/L |
|
Urobilinogen |
Urine |
1-3.5 |
mg/24 h |
|
1.7 |
1.7-5.9 |
|
mol/d |
|
Valine |
Plasma |
1.7-3.7 |
mg/dL |
|
85.361 |
145-315 |
|
mol/L |
|
Valproic acid |
Serum, plasma |
50-100 |
g/mL |
|
6.934 |
346-693 |
|
mol/L |
|
Vancomycin |
Serum, plasma |
20-40 |
g/mL |
|
0.69 |
14-28 |
|
mol/L |
|
Vanillylmandelic acid (VMA) |
Urine |
2.1-7.6 |
mg/24 h |
|
5.046 |
11-38 |
|
mol/d |
|
Vasoactive intestinal polypeptide |
Plasma |
<50 |
pg/mL |
|
0.296 |
<15 |
|
pmol/L |
|
Vasopressin |
Plasma |
1.5-2.0 |
pg/mL |
|
0.923 |
1.0-2.0 |
|
pmol/L |
|
Verapamil |
Serum, Plasma |
100-500 |
ng/mL |
|
2.2 |
220-1100 |
|
nmol/L |
|
Vitamin A (retinol) |
Serum |
30-80 |
g/dL |
|
0.0349 |
1.05-2.80 |
|
mol/L |
|
Vitamin B1 (thiamine) |
Serum |
0-2 |
g/dL |
|
29.6 |
0-75 |
|
nmol/L |
|
Vitamin B2 (riboflavin) |
Serum |
4-24 |
g/dL |
|
26.6 |
106-638 |
|
nmol/L |
|
Vitamin B3 |
Whole blood |
0.2-1.8 |
g/mL |
|
4.56 |
0.9-8.2 |
|
mol/L |
|
Vitamin B6 (pyridoxine) |
Plasma |
5-30 |
ng/mL |
|
4.046 |
20-121 |
|
nmol/L |
|
Vitamin B12 |
Serum |
160-950 |
pg/mL |
|
0.7378 |
118-701 |
|
pmol/L |
|
Vitamin C (ascorbic acid) |
Serum |
0.4-1.5 |
mg/dL |
|
56.78 |
23-85 |
|
mol/L |
|
Vitamin D (1,25 dihydroxyvitamin D) |
Serum |
25-45 |
pg/mL |
|
2.6 |
60-108 |
|
pmol/L |
|
Vitamin D (25-hydroxyvitamin D) |
Plasma |
14-60 |
ng/mL |
|
2.496 |
35-150 |
|
nmol/L |
|
Vitamin E (a-tocopherol) |
Serum |
43221 |
g/mL |
|
23.22 |
15676 |
|
mol/L |
|
Vitamin K |
Serum |
0.13-1.19 |
ng/mL |
|
2.22 |
0.29-2.64 |
|
nmol/L |
|
Warfarin |
Serum, plasma |
1.0-10 |
g/mL |
|
3.247 |
3.2-32.4 |
|
mol/L |
|
White blood cell count |
Whole blood |
4500-11000 |
/ L |
|
0.001 |
4.5-11.0 |
|
×109/L |
|
Differential count |
Neutrophils-segmented |
Whole blood |
1800-7800 |
/ L |
|
0.001 |
1.8-7.8 |
|
×109/L |
|
Neutrophils-bands |
Whole blood |
0-700 |
/ L |
|
0.001 |
0-0.70 |
|
×109/L |
|
Lymphocytes |
Whole blood |
1000-4800 |
/ L |
|
0.001 |
1.0-4.8 |
|
×109/L |
|
Monocytes |
Whole blood |
0-800 |
/ L |
|
0.001 |
0-0.80 |
|
×109/L |
|
Eosinophils |
Whole blood |
0-450 |
/ L |
|
0.001 |
0-0.45 |
|
×109/L |
|
Basophils |
Whole blood |
0-200 |
/ L |
|
0.001 |
0-0.20 |
|
×109/L |
|
Differential count (number fraction) |
Neutrophils-segmented |
Whole blood |
56 |
% |
|
0.01 |
0.56 |
|
Proportion of 1.0 |
|
Neutrophils-bands |
Whole blood |
3 |
% |
|
0.01 |
0.03 |
|
Proportion of 1.0 |
|
Lymphocytes |
Whole blood |
34 |
% |
|
0.01 |
0.34 |
|
Proportion of 1.0 |
|
Monocytes |
Whole blood |
4 |
% |
|
0.01 |
0.04 |
|
Proportion of 1.0 |
|
Eosinophils |
Whole blood |
2.7 |
% |
|
0.01 |
0.027 |
|
Proportion of 1.0 |
|
Basophils |
Whole blood |
0.3 |
% |
|
0.01 |
0.003 |
|
Proportion of 1.0 |
|
Zidovudine |
Serum, plasma |
0.15-0.27 |
g/mL |
|
3.7 |
0.56-1.01 |
|
mol/L |
|
Zinc |
Serum |
75-120 |
g/dL |
|
0.153 |
11.5-18.5 |
|
mol/L |
|
The information in this table is adapted from and based on the following sources: (1) Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Laboratory reference values. N Engl J Med. 2004;351(15):1548-1563; (2) Young DS, Huth EJ. SI Units for Clinical Measurement. Philadelphia, PA: American College of Physicians; 1998; (3) Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. 20th ed. Philadelphia, PA: WB Saunders; 2001; (4) Kasper DL, Braunwald E, Fauci AS, et al, eds. Harrison's Principles of Internal Medicine, 16th ed. New York, NY: McGraw Hill; 2004; and (5) Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd ed. Philadelphia, PA: WB Saunders; 2004.